pamidronate has been researched along with Thyroid Neoplasms in 6 studies
Thyroid Neoplasms: Tumors or cancer of the THYROID GLAND.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 62-yr-old woman with thyroid carcinoma metastatic to bone, and a history of subclinical hypoparathyroidism was admitted to the hospital in hypocalcemic crisis 5 wk after receiving iv pamidronate." | 7.71 | Prolonged, symptomatic hypocalcemia with pamidronate administration and subclinical hypoparathyroidism. ( Jonklaas, J; Mishra, A; Wong, L, 2001) |
| "A 62-yr-old woman with thyroid carcinoma metastatic to bone, and a history of subclinical hypoparathyroidism was admitted to the hospital in hypocalcemic crisis 5 wk after receiving iv pamidronate." | 3.71 | Prolonged, symptomatic hypocalcemia with pamidronate administration and subclinical hypoparathyroidism. ( Jonklaas, J; Mishra, A; Wong, L, 2001) |
| "Skeletal metastases from thyroid cancer are poorly responsive to medical or radioiodine treatment." | 2.70 | Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer. ( Abbruzzese, A; Caraglia, M; Ciccarelli, A; Fonderico, F; Lupoli, G; Martignetti, A; Nuzzo, V; Vitale, G, 2001) |
| "We found that urinary markers of bone resorption are best measured on 2-hour fasting samples, because results on random urine showed poor precision and less decline with therapy." | 2.69 | Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates. ( Garber, J; Greenspan, SL; Lee, SL; Moses, AC; Rosen, HN; Ross, DS, 1998) |
| "This study presents 3 cases of refractory pain from bone metastases due to thyroid, colorectal and hepatocellular carcinoma." | 1.32 | [Bisphosphonate as an adjuvant therapy for the pain of bone metastases, 3 cases]. ( Hattori, S; Kudo, K; Miyakawa, H; Noguchi, T; Okuda, K, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, S | 1 |
| Miyakawa, H | 1 |
| Okuda, K | 1 |
| Kudo, K | 1 |
| Noguchi, T | 1 |
| Solomon, CG | 1 |
| Dluhy, RG | 1 |
| Rosen, HN | 2 |
| Moses, AC | 2 |
| Garber, J | 2 |
| Ross, DS | 2 |
| Lee, SL | 2 |
| Ferguson, L | 1 |
| Chen, V | 1 |
| Lee, K | 1 |
| Greenspan, SL | 2 |
| Mishra, A | 1 |
| Wong, L | 1 |
| Jonklaas, J | 1 |
| Vitale, G | 1 |
| Fonderico, F | 1 |
| Martignetti, A | 1 |
| Caraglia, M | 1 |
| Ciccarelli, A | 1 |
| Nuzzo, V | 1 |
| Abbruzzese, A | 1 |
| Lupoli, G | 1 |
3 trials available for pamidronate and Thyroid Neoplasms
| Article | Year |
|---|---|
Randomized trial of pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate.
Topics: Adult; Analysis of Variance; Antineoplastic Agents; Bone Density; Depression, Chemical; Diphosphonat | 1998 |
Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates.
Topics: Alkaline Phosphatase; Amino Acids; Antineoplastic Agents; Biomarkers; Bone and Bones; Bone Resorptio | 1998 |
Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Analgesics; Anti-Inflammatory Agents; Bone Neoplasms; Bone | 2001 |
3 other studies available for pamidronate and Thyroid Neoplasms
| Article | Year |
|---|---|
[Bisphosphonate as an adjuvant therapy for the pain of bone metastases, 3 cases].
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Hepatocellular; Diphosphonates; Female; Hum | 2004 |
Paraneoplastic endocrine syndromes.
Topics: Acromegaly; Adrenocorticotropic Hormone; Aminoglutethimide; Bromocriptine; Calcitonin; Cushing Syndr | 1994 |
Prolonged, symptomatic hypocalcemia with pamidronate administration and subclinical hypoparathyroidism.
Topics: Antineoplastic Agents; Bone Neoplasms; Calcitonin; Calcium Carbonate; Diphosphonates; Female; Humans | 2001 |